title: Cardiac MRI of acute coronary syndrome.
abstract: Acute coronary syndrome (ACS) is a major cause of morbidity and mortality worldwide. New serological biomarkers, such as troponins, have improved the diagnosis of ACS; however, the diagnosis of ACS can still be difficult as there is marked heterogeneity in its presentation and significant overlap with other disorders presenting with chest pain. Evidence is accumulating that cardiac MRI provides information that can aid the detection and differential diagnosis of ACS, guide clinical decision-making and improve risk-stratification after an event. In this review, we present the relevant cardiac MRI techniques that can be used to detect ACS accurately, provide differential diagnosis, identify the sequelae of ACS, and determine prognostication after ACS.
authors.forename: Shamruz
authors.initials: S
authors.lastname: Akerem Khan
authors.affiliation: Department of Radiology, Mayo Clinic, 200 First Street, Southwest Rochester, MN 55905, USA.
authors.forename: Shamruz Akarem
authors.initials: SA
authors.lastname: Khan
authors.forename: Eric E
authors.initials: EE
authors.lastname: Williamson
authors.forename: Thomas A
authors.initials: TA
authors.lastname: Foley
authors.forename: Ethany L
authors.initials: EL
authors.lastname: Cullen
authors.forename: Phillip M
authors.initials: PM
authors.lastname: Young
authors.forename: Philip A
authors.initials: PA
authors.lastname: Araoz
mesh_terms: D054058:Acute Coronary Syndrome / Q000175:diagnosis*; D015415:Biomarkers / Q000032:analysis; D003287:Contrast Media; D003937:Diagnosis, Differential; D005080:Exercise Test; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D011379:Prognosis; D018570:Risk Assessment
chemical_list: D015415:Biomarkers; D003287:Contrast Media